Regentis Biomaterials RGNT
NYSE RGNT
$1.51 +0.04 (+2.72%)
As of: Oct 21, 2026 · 11:11 AM EDT

Regentis Biomaterials (RGNT) Common Equity (2024 - 2026)

Updated

Regentis Biomaterials (RGNT) recorded Common Equity of $7.68 million in Q2 2026.

Analysis

Regentis Biomaterials (RGNT) Common Equity (2024 - 2026) Analysis & Trends

At the end of FY2025, Regentis Biomaterials reported Common Equity of $4.74 million.

  • Across earlier years, Common Equity came in at -$41.1 million in FY2024 and -$45.91 million in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Common Equity (Qtr)
1 Thermo Fisher Scientific 260.30 Bn 239.33 Bn 4.88 Bn 52.69 Bn
2 Abbott Laboratories 170.90 Bn 141.33 Bn 7.27 Bn 51.76 Bn
3 Danaher 164.81 Bn 148.62 Bn 3.61 Bn 52.59 Bn
4 Intuitive Surgical 152.46 Bn 131.89 Bn 1.96 Bn 18.30 Bn
5 Medtronic 119.28 Bn 84.53 Bn 6.34 Bn 50.85 Bn
6 Stryker 112.91 Bn 99.03 Bn 4.50 Bn 23.99 Bn
7 Boston Scientific 64.87 Bn 59.63 Bn 3.85 Bn 25.17 Bn
8 Becton Dickinson 53.24 Bn 50.39 Bn 2.32 Bn 24.42 Bn
9 Edwards Lifesciences 50.42 Bn 34.43 Bn 1.35 Bn 10.72 Bn
10 Regentis Biomaterials 855,783.43 855,783.43 - 7.68 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 7.68 Mn
Dec 31, 2025 4.74 Mn
Dec 31, 2024 -41.10 Mn
API Access

Regentis Biomaterials Common Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=common-equity&ticker=RGNT&period=max&api_key=YOUR_API_KEY